EUVIMEDEUVIMED entdecken
Open Access

18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway

Dawei Xiong, Hongfeng Dai iD

Clinical and Experimental Pharmacology and Physiology · 2026

DOI: 10.1111/1440-1681.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2026. Verfasst von Dawei Xiong und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Wuhan Institute of Bioengineering, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Autophagy, Epithelial-Mesenchymal Transition, Glycyrrhetinic Acid. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Project of excellent young and middle-aged scientific and technological innovation team of colleges and universities in Hubei province, The first batch of school-level scientific research project of Wuhan Institute of Bioengineering in 2024 "preparation of sustained-release microspheres with to….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) is one of the most common malignancies in men, and its progression is closely related to epithelial–mesenchymal transition (EMT) and autophagy imbalance. 18β‐Glycyrrhetinic acid (18β‐GA) has been reported to exhibit various anti‐tumour activities. This study aims to systematically evaluate the impact of 18β‐GA on the malignant biological behaviours of PCa and explore its potential molecular mechanisms.

Methods

The human PCa cell lines LNCaP and PC‐3 were used to evaluate the inhibitory effects of 18β‐GA on malignant progression. The potential mechanisms were further explored by assessing EMT markers, autophagy‐related proteins and angiogenesis. The role of the PTEN/PI3K/mTOR pathway in 18β‐GA's effects was explored through siRNA‐mediated PTEN knockdown and Western blot analysis. A PCa xenograft model was established in vivo to assess the impact of 18β‐GA on tumour growth.

Results

18β‐GA significantly inhibited the viability, proliferation, migration and invasion of LNCaP and PC‐3 cells, while promoting apoptosis, with no significant toxicity to RWPE‐1 cells. 18β‐GA upregulated E‐cadherin and Claudin‐1, while downregulating N‐cadherin, Vimentin, Snail and MMP2/9, thus inhibiting the EMT process and reducing the angiogenesis capacity and VEGF expression in HUVECs. Additionally, 18β‐GA increased the LC3‐II/LC3‐I ratio, upregulated Beclin1 and ATG7 and downregulated p62, indicating activation of autophagic flux. Mechanistic studies revealed that 18β‐GA upregulated PTEN expression and inhibited PI3K and mTOR phosphorylation. PTEN knockdown partially reversed its effects on autophagy, EMT and malignant phenotypes. In vivo experiments further confirmed that 18β‐GA significantly suppressed xenograft tumour growth and exhibited anti‐tumour effects.

Conclusion

18β‐GA inhibits the malignant progression of PCa cells and xenograft tumour growth by upregulating PTEN and inhibiting the PI3K/mTOR axis, synergistically activating autophagy and inhibiting EMT and angiogenesis. 18β‐GA holds promise as a potential anti‐PCa drug targeting the PTEN/PI3K/mTOR pathway, jointly regulating autophagy and EMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAutophagyEpithelial-Mesenchymal TransitionGlycyrrhetinic AcidTOR Serine-Threonine KinasesPTEN PhosphohydrolasePhosphatidylinositol 3-KinasesDisease ProgressionMaleHumansAnimalsSignal TransductionCell Line, TumorMice, NudeMiceCell ProliferationCell MovementXenograft Model Antitumor Assays

Stichwörter der Autor:innen

18β‐glycyrrhetinic acidPTEN/PI3K/mTOR pathwayautophagyepithelial–mesenchymal transitionprostate cancer

Substanzen

Glycyrrhetinic AcidTOR Serine-Threonine KinasesPTEN PhosphohydrolasePhosphatidylinositol 3-Kinases18alpha-glycyrrhetinic acidPTEN protein, humanMTOR protein, human

Autor:innen und Institutionen

  • School of Medicine, Wuhan Institute of Bioengineering, Wuhan, Hubei, China.
  • Department of Urology II, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

ORCID-Profile: Hongfeng Dai

Förderung

  • Project of excellent young and middle-aged scientific and technological innovation team of colleges and universities in Hubei province
  • The first batch of school-level scientific research project of Wuhan Institute of Bioengineering in 2024 "preparation of sustained-release microspheres with to…

Zitieren

APA

Xiong, D., & Dai, H. (2026). 18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70156

Vancouver

Xiong D, Dai H. 18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway. Clinical and Experimental Pharmacology and Physiology. 2026. doi:10.1111/1440-1681.70156

BibTeX
@article{Xiong2026,
  author = {Xiong, Dawei and Dai, Hongfeng},
  title = {18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2026},
  doi = {10.1111/1440-1681.70156}
}
Kostenlos starten →